Related Experiment Videos
[Does HDL-cholesterol determination facilitate the assessment of risk in coronary patients?]
Schweizerische Medizinische Wochenschrift
|December 17, 1983
Insights
High-density lipoprotein cholesterol (HDL-C) levels were analyzed in coronary heart disease (CHD) patients. Results indicate HDL-C has low specificity for assessing individual CHD risk due to frequent unexpected high values.
Area of Science:
- Cardiovascular Medicine
- Clinical Biochemistry
- Lipid Metabolism
Context:
- Analysis of serum lipids in 153 patients with established coronary heart disease (CHD).
- Focus on evaluating the predictive value of high-density lipoprotein cholesterol (HDL-C).
- Investigating the role of lipid profiles in cardiovascular risk assessment.
Purpose:
- To determine the risk potential and diagnostic utility of HDL-cholesterol in patients with proven CHD.
- To assess the specificity of HDL-C as a biomarker for coronary artery disease.
- To understand the limitations of HDL-C in individual cardiovascular risk stratification.
Summary:
- Serum lipid profiles, including cholesterol, triglycerides, and HDL-C, were measured in 153 CHD patients.
- The study found that HDL-C exhibits low specificity in this cohort, with many patients showing unexpectedly high levels.
- This finding suggests that HDL-C alone has limited utility for evaluating an individual's specific risk of developing CHD.
Impact:
- Highlights the limitations of using HDL-C as a sole indicator for CHD risk assessment.
- Suggests a need for re-evaluation of HDL-C's role in cardiovascular risk models.
- Informs clinical practice regarding the interpretation of lipid panels for patients with existing heart disease.
Abstract:
Serum lipids (cholesterol, triglycerides, HDL-cholesterol) were analyzed in 153 patients with proven coronary heart disease (CHD) with the target to characterize the risk potential of HDL-cholesterol. It turns out, that the specificity of HDL-C is low (too many unexpected high values in CHD). Consequently this parameter is of little use in evaluating the individual risk for CHD.